03:44 PM EST - Valeant Pharmaceuticals International, Inc. : announced that Valeant's Medicis division, a leader in facial injectables and professional skin care, has formed a collaboration with Mentor Worldwide LLC, the U.S. market leader in breast aesthetics, to enter certain of their non-reimbursed products into a combined physician loyalty program. Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading up $3.32 at $94.00.
